• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Model Number VS-402
Device Problem Defective Device (2588)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/06/2020
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Physician was attempting to use a venaseal occluding device during procedure to treat 55cm of the great saphenous vein (gsv).Ifu was followed.A guide wire was used in the insertion of catheter.It was reported that the delivery catheter and gun were prepped according to ifu.After multiple successful deliveries of adhesive and prior to removal of venaseal delivery catheter from patient, final delivery was attempted and trigger was pulled, although the syringe plunger did not move forward, no more adhesive entered the delivery catheter.After multiple unsuccessful attempts at depressing the trigger on gun with no adhesive advancing, physician elected to end the procedure and remove the device from the patient.Patient treated successfully and was unharmed.There was no patient injury reported.
 
Manufacturer Narrative
Additional information: the issue occurred at end of procedure and the desired length of treatment had already been completed.The vein is reported to have closed.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Product analysis: the venaseal was returned to medtronic investigation lab for evaluation.The returned contents of the venaseal system included a dispensing gun; 1 ml syringe, blue introducer, and venaseal catheter.A visual inspection of the returned venaseal showed the plunger of the syringe was broken which connected to the dispensing gun.The dispensing gun was connected to the venaseal catheter, which was loaded in the introducer.Dried adhesive was noted at the distal tip of catheter and continued for approximately 0.4cm.A kink to the blue introducer was observed at the distal edge of the hub.A 3ml syringe from the lab was connected to the returned dispensing gun.The plunger was retracted completely and inserted the dispensing gun.It took 38 trigger pulls before plunger of the syringe advanced completely.On second testing round it took 39 trigger pulls, then on the 3rd attempt the plunger advanced after 39 trigger pulls.It should be noted, during each test the responsiveness of the gun was not consistent.The plunger would not move after some trigger pulls, but then advance during others.The dispensing gun was opened up for evaluation.The spacing of the friction grip measured at 0.0715".Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Correction: this event was filed as ¿reportable malfunction¿ for gun failing to advance following the start of adhesive delivery.On review, it was deemed that the issue of the gun failing to advance following the start of adhesive delivery has never caused or contributed or is likely to cause or contribute to a death or serious injury and therefore do not meet the criteria for a reportable malfunction.This event reported via mdr were due to caution, and thus conservatively reported.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key9934938
MDR Text Key188118748
Report Number9612164-2020-01508
Device Sequence Number1
Product Code PJQ
UDI-Device Identifier00643169986268
UDI-Public00643169986268
Combination Product (y/n)N
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Notification
Type of Report Initial,Followup,Followup,Followup
Report Date 04/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Model NumberVS-402
Device Catalogue NumberVS-402
Device Lot Number57291
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/25/2020
Initial Date Manufacturer Received 03/10/2020
Initial Date FDA Received04/08/2020
Supplement Dates Manufacturer Received04/27/2020
04/28/2020
03/25/2021
Supplement Dates FDA Received04/28/2020
05/06/2020
04/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number87619
Patient Sequence Number1
-
-